Analysts’ Recent Ratings Updates for Bath & Body Works (BBWI)

Bath & Body Works (NYSE: BBWI) has recently received a number of price target changes and ratings updates:

• 5/15/2025 – Bath & Body Works was given a new $39.00 price target on by analysts at Piper Sandler. They now have an “overweight” rating on the stock.
• 5/14/2025 – Bath & Body Works had its price target raised by analysts at Wells Fargo & Company from $40.00 to $44.00. They now have an “overweight” rating on the stock.
• 5/12/2025 – Bath & Body Works had its price target lowered by analysts at Barclays PLC from $38.00 to $31.00. They now have an “equal weight” rating on the stock.
• 5/6/2025 – Bath & Body Works had its price target lowered by analysts at Morgan Stanley from $49.00 to $43.00. They now have an “overweight” rating on the stock.
• 4/30/2025 – Bath & Body Works had its price target lowered by analysts at Wells Fargo & Company from $48.00 to $40.00. They now have an “overweight” rating on the stock.
• 4/22/2025 – Bath & Body Works had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $49.00 to $42.00. They now have a “buy” rating on the stock.
• 4/17/2025 – Bath & Body Works had its price target lowered by analysts at Raymond James from $46.00 to $37.00. They now have an “outperform” rating on the stock.
• 4/14/2025 – Bath & Body Works had its price target lowered by analysts at JPMorgan Chase & Co. from $47.00 to $41.00. They now have an “overweight” rating on the stock.
• 4/9/2025 – Bath & Body Works was upgraded by analysts at Piper Sandler from a “neutral” rating to an “overweight” rating. They now have a $35.00 price target on the stock, down previously from $38.00.
• 4/7/2025 – Bath & Body Works had its price target lowered by analysts at Citigroup Inc. from $48.00 to $36.00. They now have a “buy” rating on the stock.

Bath & Body Works Stock Performance

Shares of BBWI stock opened at $33.37 on Monday. The company has a market capitalization of $7.11 billion, a price-to-earnings ratio of 8.14, a PEG ratio of 0.92 and a beta of 1.87. Bath & Body Works, Inc. has a twelve month low of $24.96 and a twelve month high of $52.99. The stock’s 50 day simple moving average is $29.97 and its 200 day simple moving average is $34.00.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.04 by $0.05. The business had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. On average, analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Friday, June 6th will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.40%. Bath & Body Works’s dividend payout ratio is presently 21.98%.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. SRS Capital Advisors Inc. increased its holdings in shares of Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock worth $26,000 after buying an additional 329 shares in the last quarter. Golden State Wealth Management LLC bought a new position in Bath & Body Works in the fourth quarter valued at approximately $26,000. UMB Bank n.a. raised its stake in shares of Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock worth $35,000 after purchasing an additional 335 shares in the last quarter. Lindbrook Capital LLC grew its stake in shares of Bath & Body Works by 81.9% in the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock valued at $37,000 after buying an additional 431 shares in the last quarter. Finally, Smartleaf Asset Management LLC increased its holdings in Bath & Body Works by 135.0% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company’s stock worth $39,000 after buying an additional 582 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.